 During study treatment, regular assessments including weekly safety laboratory testing including CPK will be performed. An End-of-Therapy EOT evaluation will be performed on the day of or 1-2 days after completion of daptomycin study drug or upon early termination ET. All patients will have a post-therapy visit for Test of Cure TOCSafety performed 21-28 days following the last dose of daptomycin study drug. 